Resources from the same session
CN20 - Oral targeted therapy dose adaptation in geriatric cancer patients: A real life French cohort
Presenter: Fanny Leenhardt
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Abstract
Slides
Webcast
Why do we need phase I clinical trials?
Presenter: Martijn Lolkema
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Slides
Webcast
From referral for to participation in phase I clinical trials: Patient journeys and preliminary results in the development of an online value clarification tool
Presenter: Liza Van Lent
Session: EONS13: Phase I clinical trials: What does this mean for our patients?
Resources:
Slides
Webcast